development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly in biotechnology advances.

Fidelity Select Biotechnology Portfolio earns an Average Process Pillar rating. The primary contributor to the rating is its parent firm's excellent long-term risk-adjusted performance ...

Vir Biotechnology's Phase 1 data highlights early promise for T-cell engagers targeting HER2-positive tumors and prostate cancer with manageable safety. Vir Biotechnology's Phase 1 trials reveal ...

Cell Therapy Maker Legend Biotech Is An 'Attractive Opportunity' Due To No Material Tariff Exposure: Analyst Legend Biotech's Carvykti shows strong efficacy in multiple myeloma as U.S.-based ...

Under normal market conditions, the Fund predominantly invests in equity securities and invests at least 80% of its net assets in securities of biotechnology companies(at least 50% of its earnings ...

Vir Biotechnology Inc. advanced stock charts by Barron's. View VIR historical stock data and compare to other stocks, and exchanges.